Vasculitis News and Research

Latest Vasculitis News and Research

Columbia University Medical Center, NewYork-Presbyterian Hospital present research works at AAN meeting

Columbia University Medical Center, NewYork-Presbyterian Hospital present research works at AAN meeting

UCB seeks FDA and EMA marketing authorization for Cimzia to treat active psoriatic arthritis

UCB seeks FDA and EMA marketing authorization for Cimzia to treat active psoriatic arthritis

Circulating endothelial cells hit the mark in primary central nervous system vasculitis

Circulating endothelial cells hit the mark in primary central nervous system vasculitis

Vasculitis and the metabolic syndrome frequently co-exist

Vasculitis and the metabolic syndrome frequently co-exist

Brain microhemorrhages more common among high altitude cerebral edema survivors

Brain microhemorrhages more common among high altitude cerebral edema survivors

Anti-TNF-α therapy reduces CVD risk in patients with rheumatoid arthritis

Anti-TNF-α therapy reduces CVD risk in patients with rheumatoid arthritis

NICE decides to recommend Bristol-Myers Squibb’s YERVOY for treatment of advanced melanoma

NICE decides to recommend Bristol-Myers Squibb’s YERVOY for treatment of advanced melanoma

Clinical and demographic factors impact visual acuity in retinal vasculitis

Clinical and demographic factors impact visual acuity in retinal vasculitis

ANCA-associated vasculitis not a single clinical entity

ANCA-associated vasculitis not a single clinical entity

Anthera announces final set of clinical data from blisibimod Phase 2b study on SLE

Anthera announces final set of clinical data from blisibimod Phase 2b study on SLE

Anthera announces results from blisibimod Phase 2b study on SLE

Anthera announces results from blisibimod Phase 2b study on SLE

SQI Diagnostics reports net loss of $1,350,000 for second quarter 2012

SQI Diagnostics reports net loss of $1,350,000 for second quarter 2012

Patients prefer immediate access to radiology reports

Patients prefer immediate access to radiology reports

ChemoCentryx fourth quarter revenues increase to $26.1 million

ChemoCentryx fourth quarter revenues increase to $26.1 million

AARDA hopes to educate public on autoimmune diseases during March

AARDA hopes to educate public on autoimmune diseases during March

Progress report on commercialization of BENLYSTA to be announced at JPMorgan Healthcare Conference

Progress report on commercialization of BENLYSTA to be announced at JPMorgan Healthcare Conference

GSK obtains exclusive license to ChemoCentryx's CCX354 CCR1 inhibitor for RA

GSK obtains exclusive license to ChemoCentryx's CCX354 CCR1 inhibitor for RA

ChemoCentryx commences CCX140 Phase II trial in diabetic nephropathy

ChemoCentryx commences CCX140 Phase II trial in diabetic nephropathy

Positive results from ChemoCentryx CCX354 Phase II study on RA

Positive results from ChemoCentryx CCX354 Phase II study on RA

HHS scientists to share recent rheumatology findings at 75th ACR annual meeting

HHS scientists to share recent rheumatology findings at 75th ACR annual meeting